Concord Biotech Limited (CONCORDBIO) — Free Cash Flow Generation Index
Concord Biotech Limited (CONCORDBIO) has a Free Cash Flow Generation Index of 0.55x as of March 2025. Free cash flow of Rs1.36 Billion represents 1% of operating cash flow (Rs2.47 Billion). Explore CONCORDBIO capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Concord Biotech Limited Free Cash Flow Generation Index (2020–2025)
Historical FCF Generation Index trend for Concord Biotech Limited across 6 annual periods. For the full cash flow conversion analysis, see Concord Biotech Limited (CONCORDBIO) cash flow conversion.
Annual Free Cash Flow Generation for Concord Biotech Limited (2020–2025)
Year-by-year Free Cash Flow Generation Index for Concord Biotech Limited. Check total reinvestment intensity of Concord Biotech Limited to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (INR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.55x | Rs1.36 Billion | Rs2.47 Billion | Rs1.11 Billion | ▼ -18.7% |
| 2024 | 0.68x | Rs1.80 Billion | Rs2.65 Billion | Rs856.88 Million | ▲ +65.1% |
| 2023 | 0.41x | Rs1.01 Billion | Rs2.46 Billion | Rs1.45 Billion | ▲ +63.8% |
| 2022 | 0.25x | Rs519.70 Million | Rs2.07 Billion | Rs1.56 Billion | ▲ +211.8% |
| 2021 | -0.22x | Rs-373.59 Million | Rs1.67 Billion | Rs2.04 Billion | ▼ -5466.2% |
| 2020 | 0.00x | Rs-6.23 Million | Rs1.55 Billion | Rs1.55 Billion | — |